The Hepatic Plasma Membrane Citrate Transporter NaCT (SLC13A5) as a Molecular Target for Metformin
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Hepatic Plasma Membrane Citrate Transporter NaCT (SLC13A5) as a Molecular Target for Metformin
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-22
DOI
10.1038/s41598-020-65621-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin in 2019
- (2019) James Flory et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The multifaceted effects of metformin on tumor microenvironment
- (2019) Ivana Kurelac et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
- (2019) Marc Foretz et al. Nature Reviews Endocrinology
- Metformin as Anti-Aging Therapy: Is It for Everyone?
- (2019) Alexander A. Soukas et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Metformin
- (2018) Julie Rodriguez et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Metformin as an Anticancer Agent
- (2018) Ales Vancura et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing
- (2018) Francesco Prattichizzo et al. AGEING RESEARCH REVIEWS
- The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth
- (2018) Sam Amin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences
- (2018) Eric Fontaine Frontiers in Endocrinology
- Plasma Membrane Na+-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy
- (2017) Yangzom Bhutia et al. MOLECULES
- Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
- (2017) Yan Zheng et al. Nature Reviews Endocrinology
- Mechanism of Metformin: A Tale of Two Sites
- (2016) Ruisheng Song DIABETES CARE
- Current understanding of metformin effect on the control of hyperglycemia in diabetes
- (2016) Hongying An et al. JOURNAL OF ENDOCRINOLOGY
- New insights into the anti-diabetic actions of metformin: from the liver to the gut
- (2016) Tongzhi Wu et al. Expert Review of Gastroenterology & Hepatology
- Metformin Action: Concentrations Matter
- (2015) Ling He et al. Cell Metabolism
- Therapeutic Concentrations of Metformin: A Systematic Review
- (2015) Farshad Kajbaf et al. CLINICAL PHARMACOKINETICS
- Targeting SREBPs for treatment of the metabolic syndrome
- (2015) Selma M. Soyal et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Rapamycin: One Drug, Many Effects
- (2014) Jing Li et al. Cell Metabolism
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- The Target of Metformin in Type 2 Diabetes
- (2014) Ele Ferrannini NEW ENGLAND JOURNAL OF MEDICINE
- The Mammalian INDY Homolog Is Induced by CREB in a Rat Model of Type 2 Diabetes
- (2013) F. Neuschafer-Rube et al. DIABETES
- Diabetes: a 21st century challenge
- (2013) Paul Z Zimmet et al. Lancet Diabetes & Endocrinology
- Connecting mTORC1 signaling to SREBP-1 activation
- (2012) Inan Bakan et al. CURRENT OPINION IN LIPIDOLOGY
- AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets
- (2011) Ken Inoki et al. Annual Review of Pharmacology and Toxicology
- The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
- (2011) Lei Chen et al. Nature Reviews Endocrinology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now